Protective effects of fermented rice vinegar sediment (Kurozu moromimatsu) in a diethylnitrosamine-induced hepatocellular carcinoma animal model by Shizuma, Toru et al.
Original Article
 J. Clin. Biochem. Nutr. | July 2011 | vol. 49 | no. 1 | 31–35 doi: 10.3164/jcbn.10 112
©2011 JCBN
JCBN Journal of Clinical Biochemistry and Nutrition 0912-0009 1880-5086 the Society for Free Radical Research Japan Kyoto, Japan jcbn10-112 10.3164/jcbn.10-112 Original Article Protective effects of fermented rice vinegar 
sediment (Kurozu moromimatsu) 
in a diethylnitrosamine induced hepatocellular 
carcinoma animal model
Toru Shizuma,1,* Kazuo Ishiwata,1 Masanobu Nagano,2 Hidezo Mori1 and Naoto Fukuyama1
1Department of Physiology, School of Medicine, Tokai University, 143, Shimokasuya, Isehara, Kanagawa 259 1193, Japan
2Sakamoto Kurozu Inc., 21 15, Uenosonochou, Kagoshimashi, Kagoshima 890 0052, Japan
*To whom correspondence should be addressed.    
E mail: shizuma@is.icc.u tokai.ac.jp
??(Received 14 September, 2010; Accepted 25 October, 2010; (Received 14 September, 2010; Accepted 25 October, 2010; Published online 17 June, 2011)
Copyright © 200? JCBN 200? This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. Kurozu moromimatsu is the sediment of Kurozu, a jar fermented
Japanese black vinegar produced from unpolished rice. Here, we
examined the protective effects of Kurozu moromimatsu in a
diethylnitrosamine induced model of hepatocellular carcinoma.
Thirty two F344 rats were divided into two groups; the control
group received basal CE 2 diet, and the Kurozu moromimatsu
group received CE 2 diet containing Kurozu moromimatsu. At 16
weeks after initial intraperitoneal administration of diethylnitro 
samine (150 mg/kg/week), serum was collected from half the rats.
These rats were sacrificed and the liver was resected for histo 
logical examination of hematoxylin eosin stained sections and
assay of matrix metalloproteinase 2 and matrix metalloproteinase 
9 levels in tumor tissues. Glutathione S transferase placental form 
positive foci were evaluated by immunostaining for glutathione
S transferase placental form. The remaining rats were maintained
for evaluation of survival. There were no significant differences of
serum transaminases, tumor necrosis factor alpha, and also no
marked hepatic histological differences, between the two groups.
However, the size of hepatocellular carcinomas was greatly
decreased and the levels of activated matrix metalloproteinase 2
and  9 were significantly reduced in the Kurozu moromimatsu
group. Further, survival was significantly prolonged in the Kurozu
moromimatsu group compared with the control. These results
indicate that Kurozu moromimatsu inhibited the growth of
hepatocellular carcinoma.
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Introduction Kurozu is a traditional black vinegar produced from unpolished
rice and has been widely used in Japan as seasoning for
food or as a health supplement. Kurozu is produced mainly in
Kagoshima, Japan, by fermentation of vinegar with several bacilli
for more than one year in earthenware jars. The supernatant is
Kurozu, and the sediment at the bottom of the jars is called Kurozu
moromimatsu ( Kurozu-M), and contains high levels of amino
acids, minerals, organic materials and so on.
Anti-cancer effects of ethyl acetate extract of Kurozu have been
reported in vitro(1) and in an animal model of colon cancer.(2) We
previously reported that Kurozu-M inhibited development of
human colon cancer cells, LoVo cells, in a transplanted rodent
model.(3) On the other hand, the therapeutic effect of Kurozu-M
on hepatocellular carcinoma (HCC) has not yet been reported in
animals or humans. Recently, an anti-cancer effect of coffee drink
on HCC has been reported in humans,(4,5) and the presence of
dietary factors that inhibit HCC has been detected in an animal
model.(6) However, effective dietary factors to inhibit the develop-
ment of HCC remain to be identified.
The most common cause of HCC is thought to be hepatitis C
virus (HCV), followed by hepatitis B virus (HBV) infection in
Japan, and the number of deaths from HCC is more than 30,000/
year; it is the third most important cause of cancer death in males
in Japan. Moreover, HCC is the fifth most common cancer world-
wide.(7) Recently, drugs directed against HCC-related molecular
targets have entered clinical trial.(8) However, at present, the
impact on the survival rate in HCC patients is limited owing to
high frequencies of recurrence and metastasis and the background
of often-severe liver dysfunction.
Several matrix metalloproteinase (MMP)s, which are zinc-
dependent endopeptidases degrading the extracellular matrix, are
related to development and metastasis of various solid cancers,
including HCC.(8) Moreover, MMPs can promote the activation of
insulin-like growth factor, which promotes tumor development
and growth.(9,10) In particular, MMP-2 and MMP-9 (gelatinases)
play important roles in tumor angiogenesis and cancer growth.
HCC is typically a hypervascular cancer, and angiogenesis is
important in its early stages.(11) Therefore, inhibition of angio-
genesis, for example, by inhibition of activation of MMPs, might
improve the prognosis of HCC patients.
In this work, we examined the protective effects of Kurozu-M in
a dietheylnitrosamine (DEN)-induced HCC experimental model,
focusing on suppression of activated MMPs.
Materials and Methods
Experimental animal model. The experimental procedures
were approved by the Animal Experimentation Committee,
School of Medicine, Tokai University, Japan. Thirty-two F344
male rats (8 weeks of age) were obtained from CLEA Japan Inc.
(Tokyo, Japan) and bred under specific pathogen-free conditions
at a room temperature of 24–25°C, under constant humidity, with
a 12-h light/dark cycle. The rats were randomized into two groups;
the control group received basal CE-2 diet (CLEA Japan Inc.,
Tokyo, Japan) (n = 16) and the Kurozu-M group received CE-2
diet including 2% Kurozu-M (Sakamoto Kurozu Inc., Kagoshima,
Japan) (n = 16). The volume of Kurozu-M added to the diet of rats
was chosen based on the typical volume of ingestion by humans,
adjusted for body weight. Basal CE-2 diet and special diet
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including Kurozu-M were started from a week before the initial
administration of DEN (Sigma, St. Louis). Administrations of
DEN (150 mg/kg/week) were performed by intraperitoneal injec-
tion 3 times during 3 weeks. The concentration of iron in basal
CE-2 diet was 32.2 mg/100 g (data from manufacturer) and that of
CE-2 diet containing 2% Kurozu-M, used as the experimental diet
in this study, was calculated to be 31.7 mg/100 g (based on iron
concentration of 4.8 mg/100 g in Kurozu-M).
Preliminary examinations showed that liver tumors more than
10 mm in size at the major axis were present in all rats (n = 5) of
the control group at 12 weeks after initial administration of DEN.
Serum examinations. At 16 weeks after initial administra-
tion of DEN, serum levels of albumin, transaminases (AST and
ALT), hyaluronic acid, tumor necrosis factor (TNF)-α (ELISA),
interleukin (IL)-2 (ELISA) were measured (SRL Inc., Tokyo,
Japan) in half of the rats (each group; n = 8) of both groups.
Histology and immunostaining. Immediately after collec-
tion of serum, the same rats (each group; n = 8) were sacrificed
under anesthesia induced with isoflurane (Wako Pure Chemicals,
Osaka, Japan) and the livers were resected. The presence of liver
tumors was confirmed macroscopically. Moreover, microscopic
examination of liver tissues by hematoxylin-eosin (HE) staining
was performed as usual. Further, glutathione S-transferase placental
form (GST-P) was examined as a marker of HCC and pre-
cancerous lesions. Procedures of GST-P staining were as follows.
Livers were fixed, embedded in paraffin and sectioned. Sections of
3 μm thickness were treated with rabbit anti-rat GST-P antibody
(MBL International Co., Nagoya, Japan) and then with secondary
antibody and avidin-biotin complex (Ultratech HRP Kit; Beckman
Coulter Inc., Ontario, Canada). The sites of peroxidase binding
were visualized with diaminobenzidine. Sections were counter-
stained with hematoxylin. Evaluation of GST-P-positive foci was
performed based on size (tranverse diameter) and number per
slice (transverse axis) of the right lobe of liver in all 16 rats.
Semi-quantitative analysis of GST-P-positive foci was done using
Adobe Photoshop CS3 Extended. All evaluations were performed
by a pathologist who was blinded as to the treatment the animals
had received.
MMP 2 assay. Levels of activity of MMP-2 were assayed with
a commercial kit (Amersham Pharmacia Biotech, Buckinghamshire,
UK). Tissues of HCCs were homogenized by centrifugation, and
the supernatant was used as the sample. Samples were added to
wells coated with MMP-2 antibody and incubated. Each sample
was activated with 0.5 mM aminophenylmercuric acetate (APMA).
The absorbance was read at 405 nm on a microplate reader. The
method used was as described in our previous report.(3)
MMP 9 assay. Standards and samples were run in the same
manner as described for MMP-2 on a microplate coated with
MMP-9 antibody, and 1 mM APMA was used for activation.
The absorbance was read at 405 nm on a microplate reader. The
method used was as described in our previous report.(3)
Survival rates. The remaining rats (each group; n = 8) in
both groups were continued on the same diets and under same
conditions. Survival was examined during 48 weeks after the
initial administration of DEN. Differences in the survival rates of
the non-sacrificed rats (each group; n = 8) among the two groups
after initial DEN administration were analyzed by the Kaplan-
Meier method.
Statistical analysis. Statistical analysis of serum parameters,
MMP-2 and MMP-9 levels, and numbers and sizes of GST-P-
positive foci in the liver among rats of the two groups (each group;
n = 8) was done with the unpaired t test. The criterion of
significance was p<0.05. Levels of serum albumin, transaminases,
hyaluronic acid, TNF-α, IL-2 and MMP-2 and MMP-9 levels
were given as mean and standard deviation.
Results
Serum examinations. Levels of serum albumin (g/dl) were
4.3 ± 0.2 in the control group and 4.2 ± 0.2 in the Kurozu-M
group. Levels of serum AST/ALT (IU/l) were 236 ± 67/206 ± 51
in the control group and 209 ± 64/183 ± 49 in the Kurozu-M
group. There was no significant difference in the levels of albumin
or AST/ALT between the two groups. Moreover, the levels of
serum hyaluronic acid (ng/ml) were 37.8 ± 3.8 in the control
group, and 35.1 ± 2.8 in the Kurozu-M group. There was no
significant difference in the level of hyaluronic acid between the
two groups.
As regards the levels of cytokines, the levels of TNF-α (pg/ml)
were 3.4 ± 1.7 in the control group and 3.1 ± 1.8 in the Kurozu-M
group. Levels of IL-2 (U/ml) were 1.6 ± 0.6 in the control group
and 1.4 ± 0.4 in the Kurozu-M group. There were no significant
differences in the levels of either of the cytokines between the two
groups.
Histology and GST P staining. In macroscopic examination
of the resected liver, white tumors with a size of more than 10 mm
at the major axis were apparent in all rats in the control group
(Fig. 1). Such large tumors were not found in the Kurozu-M group.
In microscopic examination of HE-stained liver sections, focal
necrosis of liver cells and invasion of inflammatory cells in portal
areas (corresponding to mild chronic hepatitis in humans) were
found in both groups. However, fibrosis or piecemeal necrosis was
not obvious. Moreover, there were no marked background changes
of liver tissues in the two groups (Fig. 2 a and b).
As for GST-P staining, the numbers of GST-P-positive foci were
12.2 ± 6.8 in the control group, and 10.7 ± 5.3 in the Kurozu-M
group. There was no significant difference between the two groups.
However, large HCC with a diameter of more than 10 mm was
noted in liver in all animals of the control group. On the other
hand, in the Kurozu-M group, no lesion of more than 3 mm in
diameter was found in any liver. The size (mm) of GST-P-positive
foci in the Kurozu-M group (0.89 ± 0.46) was significantly
(p<0.001) reduced compared with the control (7.35 ± 5.31) (Fig. 3
and 4).
MMP 2 and MMP 9 levels in tumor tissues. Total MMP-2
amounted to 6.7 ± 2.6 ng/mg protein in the control group and
3.6 ± 1.7 ng/mg protein in Kurozu-M group. The corresponding
values for activated MMP-2 were 0.28 ± 0.12 ng/mg protein and
0.12 ± 0.06 ng/mg protein, respectively. Total MMP-9 amounted
to 20.6 ± 4.6 ng/mg protein in the control group and 12.0 ± 2.7 ng/
mg protein in Kurozu-M group. The corresponding values for
activated MMP-9 were 1.17 ± 0.38 ng/mg protein and 0.51 ±
Fig. 1. Photograph of a representative resected liver tumor. Multiple
white tumors were apparent in the control group. The diameter of the
tumor shown, at the major axis, was 14 mm. J. Clin. Biochem. Nutr. | July 2011 | vol. 49 | no. 1 | 33
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0.19 ng/mg protein, respectively. Total and activated MMP-2
and MMP-9 levels were all significantly (p<0.001) reduced in the
Kurozu-M group compared with the control group (Fig. 5).
Survival. In the control group, all 8 rats died within 36 weeks
after initial DEN administration. On the other hand, the survival
rate in the Kurozu-M group was 37.5% (3/8) at 48 weeks. The
survival rate in the Kurozu-M group was significantly higher than
that in the control group (p<0.001) (Fig. 6).
Discussion
Kurozu-M treatment markedly inhibited growth of HCC and
improved survival in the DEN-induced HCC animal model. One
of the mechanisms of its anti-cancer effects was considered to be
suppression of activated MMP-2 and MMP-9, which degrade the
extracellular matrix, thereby promoting the growth and metastasis
of various solid cancers.
Occurrence of HCC is generally associated with liver fibrosis
or inflammatory changes. Clinically, chronic hepatitis or liver
cirrhosis (LC) with HCV infection often leads to HCC. For
example, the occurrence rate of HCC in LC patients with HCV
infection is 6–8%/year in Japan.(12) In patients with hepatitis,
inflammation and regeneration in the liver are associated with
Fig. 2. Findings of liver tissues. Focal necrosis of liver cells and invasion of inflammatory cells in portal areas were found in both groups. However,
fibrosis or piecemeal necrosis was not obvious. (a: control group, b: Kurozu M group; HE ×200).
Fig. 3. Findings of GST P staining. Large GST P positive foci with a diameter of 20 mm was noted in liver in the control group (a). On the other
hand, in the Kurozu M group, no lesion of more than 3 mm in diameter was found in liver (b).
Fig. 4. Numbers and size of GST P positive foci. The numbers of GST P 
positive foci were 12.2 ± 6.8 in the control group, and 10.7 ± 5.3 in the
Kurozu M group. There was no significant difference between the two
groups. The size (mm) of GST P positive foci in the Kurozu M group
(0.89 ± 0.46) was significantly (p<0.001) reduced compared with the
control (7.35 ± 5.31).doi: 10.3164/jcbn.10 112
©2011 JCBN
34
development of HCC,(13) though exceptionally, HCC rarely develops
in patients with autoimmune hepatitis. However, our study revealed
that the extents of histological liver fibrosis or inflammatory
change, as well as the serum levels of transaminases or hyaluronic
acid as a marker of liver fibrosis, were not significantly different
between the Kurozu-M group and the control. Therefore, inhibi-
tion of HCC growth in the Kurozu-M group in this study was
not associated with differences in background factors. It has been
reported that iron overload, which induces oxidative stress, aggra-
vates liver diseases(14) and increases the risk of malignancy.(15)
However, the levels of iron in the diets of the control and Kurozu-
M groups were essentially the same in this study.
Increased levels of the gelatinases; MMP-2 and MMP-9 are
considered prognostic for solid cancers, including HCC.(16) In fact,
it has been suggested that inhibition of gelatinases can suppress
development of HCC in an animal model.(17) Since activated
MMP-2 promotes angiogenesis,(18) suppression of MMP-2 and
MMP-9 by Kurozu-M may have led to inhibition of HCC growth
in our model. We found that the number of GST-P-positive foci
(which were estimated foci corresponding to low-grade dysplastic
nodules) in the Kurozu-M group showed no difference from the
control, but the size of developed GST-P-positive foci was greatly
decreased. Thus, a possible explanation is that Kurozu-M inhibited
angiogenesis, which may not greatly influence the initial progres-
sion from premalignant tumor, but may be an important promoting
factor at the stage of high-grade dysplastic nodules or early HCC.
This would be consistent with our findings.
Activation of MMPs is important for carcinogenesis. MMP-2 is
activated by membrane type (MT)-1-MMP.(19) It is also activated
by peroxylnitrite(20) which exhibits cytotoxicity via direct oxida-
tion of sulfhydryl groups, leading to severe tissue damage. We
have already reported that Kurozu-M inhibits nitrotyrosine gener-
ation in colon cancer cells.(3) Nitrotyrosine is produced in vivo
via two pathways, i.e., from the reaction of tyrosine with peroxyl-
nitrite, which is generated from O2￿− and nitric oxide (NO),(21) and
from the reaction of tyrosine with nitrite, catalyzed by myeloper-
oxidase (MPO).(22) Therefore, Kurozu-M might reduce MMP-2
activation by inhibiting the generation of peroxylnitrite. In addi-
tion, MMP-9 is activated by MMP-2,(23) as well as by several
cytokines.(24) However, in our study, serum levels of TNF-α and
IL-2 were not increased.
The active component of Kurozu-M remains to be identified.
Acetic acid, which is the main component of Kurozu, is not
included in Kurozu-M. However, Kurozu-M contains amino acids,
oligopeptide, organic materials including metabolites of lactic
acid or Koji molds, minerals, saccharides, lipids, etc. Candidate
active components include branched chain amino acid (BCAA),
which are widely used for the treatment of protein malnutrition
in LC patients. It was reported that BCAA suppressed insulin-
resistance-based carcinogenesis in diabetic rats(7) and suppressed
angiogenesis in a chemical carcinogenesis model.(7) Furthermore,
various other amino acids have anti-oxidative activity, acting as
radical scavengers.(25) Therefore, various amino acids may sup-
press the generation of O2￿− or peroxylnitrite, thereby suppressing
activation of MMP-2. On the other hand, oligosaccharides are
also candidate active components, because oligosaccharides from
agar suppressed NO generation in vitro.(26) Oligosaccharides also
reduced the activity of inducible NO synthase (iNOS),(27) which
might lead to a decrease of peroxylnitrite generation. Organic
materials, including metabolites of lactic acid or Koji formed in
the earthenware jars are also potential anti-oxidants,(28) and anti-
cancer agents such as bleomycin or mitomycin C or their deriva-
tives are known to be produced as bacterial metabolites.
Fig. 5. MMP 2 and MMP 9 levels (ng/mg protein). Total MMP 2 amounted to 6.7 ± 2.6 in the control group and 3.6 ± 1.7 in Kurozu M group. The
corresponding values for activated MMP 2 were 0.28 ± 0.12 and 0.12 ± 0.06, respectively (a). Total MMP 9 amounted to 20.6 ± 4.6 in the control
group and 12.0 ± 2.7 in Kurozu M group. The corresponding values for activated MMP 9 were 1.17 ± 0.38 and 0.51 ± 0.19, respectively (b). Total and
activated MMP 2 and MMP 9 levels were all significantly (p<0.001) reduced in the Kurozu M group compared with the control group.
Fig. 6. Survival rate by the Kaplan Meier method. In the control
group, all 8 rats died within 36 weeks after initial administration of
DEN. On the other hand, the survival rate in the Kurozu M group was
37.5% (3/8) at 48 weeks. The survival rate in the Kurozu M group was
significantly higher than that in the control group (p<0.001). J. Clin. Biochem. Nutr. | July 2011 | vol. 49 | no. 1 | 35
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In conclusion, Kurozu-M inhibited the growth of HCC in a
DEN-induced HCC animal model and prolonged survival. The
active component(s) has not yet been identified, but our results
suggest that Kurozu-M may be beneficial as a dietary supplement
in humans.
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Kurozu-M Kurozu moromimatsu
HCC hepatocellular carcinoma
HCV hepatitis C virus
HBV hepatitis B virus
MMP matrix metalloproteinase
DEN diethylnitrosamine
TNF tumor necrosis factor
IL interleukin
HE hematoxylin-eosin
GST-P glutathione S-transferase placental form
APMA aminophenylmercuric acetate
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NO nitric oxide
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